Lixte Biotechnology Holdings, Inc.

Contributing Author

Recent Articles by Lixte Biotechnology Holdings, Inc.

Dec-18	Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules LIXT GlobeNewswire
Nov-25	LIXTE Biotechnology Acquires Liora Technologies' Proprietary Proton Therapy Platform for Cancer Treatment LIXT GlobeNewswire
Oct-29	LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3 LIXT GlobeNewswire
Oct-16	LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans LIXT GlobeNewswire
Sep-10	LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions LIXT GlobeNewswire
Sep-03	LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer LIXT GlobeNewswire
Aug-18	LIXTE Biotechnology Holdings Provides Corporate Update LIXT GlobeNewswire
Aug-13	LIXTE Biotechnology Holdings Updates Corporate Treasury Policy to Include Cryptocurrency LIXT GlobeNewswire
Jul-16	LIXTE Biotechnology Holdings Regains Compliance with Nasdaq's Continued Listing Requirements LIXT GlobeNewswire
Jul-09	New Clinical Findings Published in Scientific Journal Nature Validate LIXTE's Ongoing Ovarian and Colorectal Cancer Trials LIXT GlobeNewswire
Jul-08	Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering LIXT GlobeNewswire
Jul-02	Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market LIXT GlobeNewswire
Jul-01	Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market LIXT GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.